ArticleScientific reports2021

Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.

Elham Ashouri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.